Appetite, pain and nausea were the top three advocated indications for use.
Cystic fibrosis (CF) healthcare providers need to have a better understanding about whether or not cannabis has a role to play in treating symptoms, suggests a new study out of the U.S.
Investigators reached that conclusion after receiving input from 282 survey participants across all U.S. regions, 28 per cent of them being providers and 26 per cent of them being social workers. Other providers included nurses, pharmacists, dietitians and psychology care team members.
– Read the entire article at Regina Leader-Post.
